Merck | MRK - Selling And Administration Expenses

Stock Price
117.35
Daily Change
-3.40 -2.82%
Monthly
1.91%
Yearly
2.44%
Q2 Forecast
109.97

Merck reported EUR1.6B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Adidas EUR 2.68B 283M Mar/2026
Adyen EUR 156.16M 14.47M Dec/2025
Akzo Nobel EUR 804M 7M Mar/2026
Alcon AG USD 882M 19M Mar/2026
Amadeus IT EUR 497.5M 206.6M Mar/2025
Amarin USD 18.97M 1.03M Dec/2025
AstraZeneca USD 5.06B 455M Mar/2026
BASF EUR 2.13B 84M Mar/2026
Bayer EUR 3.7B 356M Mar/2026
Beiersdorf EUR 271M 51M Dec/2025
Covestro EUR 445M 8M Dec/2025
Danone EUR 4.7B 170M Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 749M 36M Mar/2026
Genmab DKK 208M 60M Dec/2025
Givaudan CHF 561M 25M Dec/2025
GlaxoSmithKline GBP 2.12B 558M Mar/2026
GRIFOLS EUR 281M 5.7M Mar/2026
Henkel EUR 3.49B 38M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Infineon EUR 379M 30M Mar/2026
Lakefront Biotherapeutics EUR 35.5M 8.91M Mar/2026
Linde USD 880M 40M Dec/2025
Merck EUR 1.6B 136M Dec/2025
Novartis USD 3.14B 296M Mar/2026
Philips EUR 1.18B 121M Mar/2026
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.33B 419M Mar/2026
UCB EUR 1.47B 193M Dec/2025